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Purpose: The aim of the present study was to examine changes in the expression of intracellular signal-transduction
pathways, specifically mitogen-activated protein kinases, following retinal ischemia-reperfusion.
Methods: Retinal ischemia was induced by elevating the intraocular pressure in porcine eyes, followed by 5, 12, or 20 h
of reperfusion. The results were compared to those of the sham- operated fellow eye. The retinal arteries and neuroretina
were isolated separately and examined. Tissue morphology and DNA fragmentation were studied using histology.
(xtracellular signal-regulated kinase 1 and 2 (ERK1/2), p38, c-junNH2-terminal kinases (JNK), and c-jun protein and
mRNA expression were examined using immunofluorescence staining, western blot, and real-time PCR techniques.
Results: Pyknotic cell nuclei, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells, and
glial fibrillary acidic protein mRNA expression were increased in ischemia, suggesting injury. Phosphorylated ERK1/2
protein levels were increased in the neuroretina following ischemia, while mRNA levels were unaltered. p38 protein and
mRNA levels were not affected by ischemia. Immunofluorescence staining for phosphorylated p38 was especially intense
in the retinal blood vessels, while only weak in the neuroretina. Phosphorylated JNK protein and mRNA were slightly
decreased in ischemia. Phosphorylated c-jun protein and mRNA levels were higher in the neuroretina after ischemia-
reperfusion.
Conclusions: Retinal ischemia-reperfusion alters expression of mitogen-activated protein kinases, particularly ERK1/2,
in the neuroretina and retinal arteries. The development of pharmacological treatment targeting these intracellular
transduction pathways may prevent injury to the eye following retinal circulatory failure.
Retinal  ischemia  due  to  local  circulatory  failure  in
diabetes, vein thrombosis, and arterial occlusion is a major
cause of sight-threatening complications and blindness [1].
Retinal ischemia leads to the formation of new blood vessels
to  meet  the  metabolic  demands  of  the  ischemic  tissue.
However, these newly formed blood vessels malfunction and
are unable to satisfy the need for the necessary nutrients. They
are not incorporated into the blood–retina barrier and will thus
bleed. This causes sight-threatening complications, such as
tractional  retinal  detachment,  vitreous  hemorrhage,
neovascular  glaucoma,  and  macular  edema  [1-3].  Today,
retinal ischemia is treated with laser photocoagulation, which
is effective but at the same time invasive and restores vision
at  the  expense  of  large  portions  of  the  retina  and  its
photoreceptors.  Although  numerous  studies  have  been
performed on ways of limiting the extent of retinal injury after
ischemia, there is still no effective pharmacological treatment
for this condition [2,4].
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Mitogen-activated  protein  kinases  (MAPKs)  are
intracellular  signal-transduction  pathways  that  have  been
shown to play a central role in the development of injury
following  ischemia  in  the  brain  and  heart  [5-8].  MAPK
inhibitors prevent the development of pathological changes in
the vasculature after both stroke and ischemic heart disease
[9,10]. Ischemia induced by middle cerebral arterial occlusion
in rats resulted in increased MAPK levels, which could be
prevented by treatment with MAPK inhibitors [11,12]. The
present study was undertaken to investigate the importance of
MAPKs  in  the  development  of  retinal  injury  following
ischemia and reperfusion.
There  are  three  main  types  of  MAPKs:  extracellular
signal-regulated kinase 1 and 2 (ERK1/2), the stress-activated
protein kinases (SAPKs)/c-junNH2-terminal kinases (JNK),
and the p38 MAPKs (p38) [13,14]. The ERK1/2 pathway is
primarily activated by mitogens, while the JNK/SAPK and
p38 pathways are activated by stress [13,14]. MAPKs regulate
gene expression, which is important in cell injury/repair and
proliferation/differentiation. Studies on MAPK and retinal
ischemia  have  recently  started  to  appear,  but  these  have
mainly involved small animals, such as rodents, and have
focused on changes in the neuroretina, not the retinal arteries
[15-17]. The blood vessels of the retina are key organs in local
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392circulatory failure, and we believe that separate analysis of the
retinal vasculature is of great importance. To enable studies
in human-like eyes with a vasculature that can be examined
separately from the neuroretina, we have recently established
a porcine model for retinal ischemia [18].
The aim of the present study was to examine changes in
the MAPK intracellular signal-transduction pathways during
the development of retinal injury following ischemia. Retinal
ischemia was induced by elevating the intraocular pressure
(IOP)  in  porcine  eyes,  followed  by  5,  12,  or  20  h  of
reperfusion. The extent of retinal injury following ischemia-
reperfusion was examined by pyknotic cell nuclei counting in
histological  sections  and  terminal  deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) assay. Glial
reactivity was assessed by quantification of glial fibrillary
acidic  protein  (GFAP)  mRNA  levels.  ERK1/2,  p38,
JNK1/2/3,  and  c-jun  mRNA  and  protein  expression  were
studied  using  immunofluorescence  staining,  western  blot
analysis, and real-time PCR techniques.
METHODS
Ethics: All procedures and animal treatment took place in
accordance with the guidelines of the Ethics Committee of
Lund  University,  the  Institute  for  Laboratory  Animal
Research  (Guide  for  the  Care  and  Use  of  Laboratory
Animals), and the ARVO statement for the Use of Animals in
Ophthalmic and Vision Research. The study was approved by
the Lund County Administrative Court under the auspices of
the Swedish Department of Agriculture.
Animals, anesthesia, and surgical procedure: A total of 38
domestic  landrace  pigs  of  both  genders,  with  a  mean
bodyweight of 70 kg each, were used for this study and were
treated as described previously [18]. In brief, a 100 mg/ml
intramuscular  injection  of  ketamine  (Ketaminol  vet™;
Farmaceutici  Gellini  S.p.A,  Aprilia,  Italy)  per  15  mg/kg
bodyweight,  in  combination  with  20  mg/ml  xylazine
(Rompun vet™; Bayer AG, Leverkusen, Germany) per 2 mg/
kg bodyweight, was used for premedication. Anesthesia was
induced  by  continuous  intravenous  infusion  of  20  mg/ml
propofol (Diprivan™; Astra Zeneca, Södertälje, Sweden) at a
dosage of 0.1–0.2 mg/kg/min in combination with intermittent
fentanyl  (Fentanyl  B.  Braun;  B.  Braun  Melsungen  AG,
Melsungen, Germany) at approximately 3.5 μg/kg/h. After
completion of the experiments, animals were euthanized by a
lethal intravenous injection of potassium 2 mmol/kg (ADDEX
Potassium Chloride, Fresenius KABI SE, Uppsala, Sweden).
Retinal ischemia was induced in one eye of each animal
by raising the IOP, while the other eye served as a control.
The posterior chamber of both eyes was cannulated with a 30-
gauge needle. The IOP was raised to 80 mmHg in one eye by
continuous infusion of a balanced salt solution for ophthalmic
irrigation  (AMO™  ENDOSOL™;  AMO  Groningen  BV,
Groningen, the Netherlands). The pressure was monitored
using a Tono-Pen®XL tonometer (Medtronic, Jacksonville,
FL). The fellow eye underwent the same surgical procedure
but without elevation of the pressure. This eye is referred to
as the “sham-operated eye” in the text and figures. Sixty
minutes later, the cannulation needles were removed to allow
reperfusion  of  the  retinal  vasculature.  Ophthalmoscopic
examination confirmed ischemia by the observation of the
blanching of retinal arteries, which indicates that 80 mmHg is
sufficient to prevent blood flow. This was confirmed directly
after elevating the IOP, during ischemia (after 30 min), and at
the end of the ischemic period (60 min). High IOP ischemia-
reperfusion is a frequently used model for experimental retinal
ischemia  research  [1]  and  has  been  described  in  several
species, including rats and rabbits. High IOP produces global
ocular ischemia, with obstruction of both the retinal and uveal
circulation,  whitening  of  the  fundus,  and  iris  pallor.  The
method is known to produce pathological features similar to
those seen after central retinal artery occlusion [1]. For more
details of the porcine model of experimental retinal ischemia,
see Gesslein et al. [18].
Tissue preparation: After 5, 12, or 20 h of reperfusion, both
eyes of the pigs were enucleated, including the optic nerve.
The eyes were dissected, the anterior segment and the vitreous
TABLE 1. REAL-TIME PCR PRIMERS.
Gene name GenBank
number
Forward primer sequence Reverse primer sequence
AJ551395 CAGCGGCCCTGAGAGAGAT TGTTAGGTCCGCAAACTTGGA
AK231529 CATGACCACACTGGCTTCTT AGCCCACAGACCAAATGTCTA
NC_010456 TGACATTCAACCCTCACAAGA ATCTGTATCCTGGCTGGAATC
CX057960 TGCAAGGTCTCTGGAGGAAT CTGAACGTGGTCATCCGTAA
AJ583707 TGCTTTGTGGAATCAAGCAC TGGGCTTTAAGTCCCGATG
AJ583708 TATTATCGGGCACCAGAAGTC AACCTTTCACCAGCTCTCTCA
CX061164 AGCCTGCTTCTTCTCCAGAGT TGTGTTGGATTTGCCTTCTG
DB818766 GAAAAGGAAGCTGGAGAGGAT CTGCTGCGTTAGCATGAGTT
U07786 CCTTCAACTCGATCATGAAGTGC CGTAGAGGTCCTTCCTGATGTCC
Gene name, GenBank number and primer sequence of the primers used in the real-time PCR analyses. All primers listed are in
their respective 5′- to 3′ orientation.
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GFAP
ERK1
ERK2
p38α
JNK1
JNK2
JNK3
c-jun
ACTBhumor were removed, and the eyecups were divided in half.
One-half  of  the  eyecup  was  used  for  routine  histology,
TUNEL assay, and immunofluorescence staining, while the
retina was dissected free from adhering tissue in the other half.
The  large  superficial  retinal  arteries  were  immediately
isolated  from  the  neuroretina  by  careful  dissection  in  a
balanced salt solution (AMOTM ENDOSOLTM) for ophthalmic
irrigation  at  4  °C.  Central  and  peripheral  pieces  of  each
remaining  neuroretina,  devoid  of  major  vessels,  were
collected.  The  retinal  and  vessel  samples  were  frozen
separately at –80 °C and stored until examined using real-time
PCR and western blot.
The eyes were fixed in 4% paraformaldehyde (Apoteket
Farmaci AB, Hackas, Sweden) for 5 h. After fixation, the
tissue  was  rinsed  in  0.1  M  Sørensen’s  phosphate  buffer
(28 mM NaH2PO4 and 72 mM Na2HPO4; pH 7.2) and washed
in the same solution with increasing concentrations of sucrose
(10% to 25%). The specimens were embedded in 30% egg
albumin and 3% gelatin and serially sectioned at 12 µm in a
cryostat.
Pyknotic  cell  count:  Pyknotic  cells  were  examined  in
hematoxylin and eosin-stained sections of eyes. Cells with
pyknotic nuclei were counted in the inner nuclear layer (INL).
For all specimens examined, the number of pyknotic cell
nuclei was determined in the central and peripheral regions
(0.25–2.25 mm and 9–10 mm from the optic nerve head,
respectively)  of  the  superior  quadrant.  The  number  of
pyknotic cells was expressed as a cell count per 0.5 mm retina
and as a percentage of the total number of cells. For each
animal, two to six sections were analyzed to obtain a mean
value for each animal.
Terminal  deoxynucleotidyl  transferase  dUTP  nick  end
labeling staining: Sections were washed with PBS (0.14 M
NaCI, 0.01 M PO4 Buffer, 0.003 M KCI, pH 7.45; Invitrogen,
Carlsbad, CA), followed by a series of incubations with 0.05
M  Tris,  pH  7.6,  between  washing.  Incubations  were  as
follows: Tris + 0.2 µg/ml proteinase K (Invitrogen) for 5 min
at 37 °C; incubation with 70% ethanol in 30% acetic acid and
water (49:9:21 v/v/v) for 5 min at −20 °C; and finally a second
incubation with Tris + 0.2 µg/ml proteinase K for 5 min at
37 °C. The sections were then blocked with PBS containing
10% normal goat serum, 1% bovine serum albumin (BSA),
and  0.003%  Triton  X-100  for  1  h  at  room  temperature.
Following blocking, sections were incubated for 1 h at 37 °C
with a TUNEL mixture (Cell Death Detection Kit, Roche,
Penzberg,  Germany)  diluted  1:2  (v/v)  with  the  blocking
solution. The sections were washed with PBS and mounted
with  antifading  mounting  medium  (Vectashield,  Vector
Laboratories Inc., Burlingame, CA).
Immunofluorescence  staining:  The  sections  were
permeabilized in a mixture of PBS and 0.25% Triton X-100
for 10 min and then blocked in PBS, 0.25% Triton X-100, 1%
BSA, and 5% normal serum for 1 h at room temperature.
Specimens were incubated overnight at 4 °C with PBS, 0.25%
Triton X-100, 1% BSA, 2% normal serum, and the primary
antibody of interest diluted (v/v): 1:200 rabbit monoclonal
phosphospecific  anti-ERK1/2  (#4370;  Cell  Signaling
Technology,  Inc.,  Danvers,  MA),  1:100  rabbit  polyclonal
phosphospecific  anti-p38  (#9211;  Cell  Signaling
Technology), 1:200 mouse monoclonal phosphospecific anti-
JNK1/2/3 (sc-6254; Santa Cruz Biotechnology, Santa Cruz,
CA),  1:100  rabbit  monoclonal  anti-c-jun  (#9165;  Cell
Figure 1. Pyknotic cells in the retinal blood vessels and neuroretina. Histopathological examination was performed by light microscopy of
hematoxylin and eosin-stained sections of porcine retina from the eye exposed to ischemia-reperfusion and the sham-operated fellow eye.
A: Artery and vein from an eye exposed to ischemia-reperfusion and the corresponding sham-operated eye. Pyknotic cell nuclei can
occasionally be observed in the ischemia-reperfusion eyes (arrows) but not in the sham-operated eyes. B: Pyknotic cell nuclei are observed
throughout the retinal sections, including the outer nuclear layer (ONL), inner nuclear layer (INL), and ganglion cell layer (GCL) of the
ischemia-reperfusion eyes (arrows) but not in the corresponding sham-operated eyes.
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394Figure 2. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining in the neuroretina. TUNEL staining of retinal
sections from pigs subject to retinal ischemia followed by 5, 12, or 20 h of reperfusion versus control (sham). Note that TUNEL-positive cells
can be detected in retinas from ischemia-reperfusion eyes but are absent in retinas from sham-operated eyes. The number of TUNEL-labeled
cells increases gradually with the duration of reperfusion. TUNEL-positive cells are observed throughout the retinal sections, including the
outer nuclear layer (ONL), inner nuclear layer (INL), and ganglion cell layer (GCL). The bottom panels are enlargements of the inserts above.
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395Signaling  Technology),  1:100  rabbit  polyclonal
phosphospecific  anti-c-jun  (#9261;  Cell  Signaling
Technology), 1:100 mouse monoclonal anti-protein kinase
Cα  (sc-8393;  Santa  Cruz  Biotechnology),  1:200  mouse
monoclonal anti-smooth muscle actin (sc-53015; Santa Cruz
biotechnology),  or  1:100  mouse  monoclonal  anti-CD31
(MCA1746; AbD Serotec, Oxford, UK). Smooth muscle actin
is commonly used for the detection of smooth muscle tissue.
CD31, also called platelet endothelial cell adhesion molecule
1  (PECAM-1),  is  expressed  by  various  cell  types  but
particularly by endothelial cells [19]. Sections were washed
with PBS buffer and incubated with the appropriate secondary
antibody  (1:50  fluorescein  isothiocyanate  [FITC]  swine
antirabbit [F0205; Dako, Glostrup, Denmark] and/or 1:400
Texas  Red  donkey  antimouse  [715–076–150;  Jackson
ImmunoResearch,  West  Grove,  PA])  for  1  h  at  room
temperature. After additional washing with PBS buffer, the
slides  were  mounted  in  antifading  mounting  medium
(Vectashield; Vector Laboratories Inc.). Epitope retrieval was
performed  on  slides  stained  for  phosphorylated  JNK  by
incubating in boiling hot citric acid buffer (pH 6.0) for 30 min
before  blocking.  Sections  incubated  without  primary  or
secondary antibody were used as negative controls to verify
the  lack  of  autofluorescence  and  unspecific  secondary
antibody staining.
Vertical sections including the optic nerve head were
examined  at  the  central  part  of  the  retina.  The  staining
intensity was viewed with a light microscope equipped for
fluorescence  microscopy  (Zeiss  Axiophoto;  Carl  Zeiss,
Oberkochen, Germany), and photographs were taken using a
digital camera mounted on the microscope (Zeiss AxioCam;
Carl  Zeiss).  For  the  purpose  of  comparisons  between
immunolabeled sections, sections from ischemia-reperfusion
and the corresponding sham-operated eyes were processed at
the  same  time  and  with  the  same  settings  to  minimize
variability. Antibody specificity in pig was verified either with
western blot, sequence homology, and/or co-localization with
more than one antibody against the same protein.
Real-time PCR: RNA was extracted from retinal arteries and
the  neuroretina  separately,  as  decribed  previously  [18].
Briefly,  the  RNA  was  extracted  in  two  different  ways.
Samples  from  the  sham-operated  and  the  ischemia-
reperfusion eyes of the same pig underwent the same RNA
extraction procedure. Using the first technique, the tissue was
homogenized with TRIzol (Invitrogen) using a metal ball and
a  TissueLyser  (Retsch,  Haan,  Germany).  Chloroform  was
added  and  samples  centrifuged.  The  supernatant  was
transferred  to  new  tubes  and  isopropanol  was  added  to
precipitate the RNA. The RNA pellet was washed with 75%
ethanol,  air  dried  and  dissolved  in  Rnase-free  water.  The
second  technique  was  employed  to  extract  RNA  with  an
RNeasy  Mini-kit  (Qiagen,  Valencia,  CA),  which  allows
simultaneous  extraction  of  protein.  The  tissue  was
homogenized  in  RTL  buffer  using  a  metal  ball  and  a
TissueLyser. The lysate was centrifuged to remove insoluble
material, and the supernatant transferred to a new tube. 70%
ethanol was added, and the sample was then applied to an
RNeasy minicolumn and centrifuged. The flow-through was
saved for protein extraction. The column was washed with
RW1 buffer and RPE buffer, and the RNA eluted with Rnase-
free  water.  The  light  absorbance  was  measured  with  a
spectrophotometer, and the RNA concentration and RNA/
Figure 3. Glial fibrillary acidic protein
mRNA levels in the neuroretina. Glial
fibrillary acidic protein (GFAP) mRNA
expression  levels  in  retinas  following
ischemia and 5 h (n=6), 12 h (n=15), or
20  h  (n=6)  of  reperfusion  (I-R)  were
assessed by real-time PCR. The mRNA
levels  were  calculated  relative  to  the
housekeeping gene β-actin (ACTB). The
results  are  shown  as  mean  values
±standard error of the mean. Statistical
analysis was performed using a paired
Student  ratio  t  test  with  Bonferroni
correction  for  multiple  comparisons.
Note that the GFAP mRNA expression
levels  increase  gradually  with  the
duration of reperfusion.
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396Figure 4. Phosphorylated extracellular signal-regulated kinase 1 and 2 (ERK1/2) immunofluorescence in the retina. Immunofluorescence
staining of retina from pigs subjected to ischemia followed by 5 (n=4), 12 (n=5), or 20 (n=4) h of reperfusion and the corresponding sham-
operated eyes. Note the enhanced staining for phosphorylated ERK1/2 following retinal ischemia, especially after 5 h of reperfusion.
Immunofluorescence staining for ERK1/2 appears to be located in the Müller cells, including both the cell bodies and in the radial processes,
and in the inner retina, probably corresponding to Müller cell endfeet and astrocytes. The abbreviations used in the figure are outer nuclear
layer (ONL), inner nuclear layer (INL), and ganglion cell layer (GCL).
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397Figure 5. Phosphorylated extracellular
signal-regulated  kinase  1  and  2
(ERK1/2)  protein  content  in  the
neuroretina  examined  using  western
blot. Data are presented as (A) mean
optical  density  and  (B)  representative
western blots from animals subjected to
ischemia and 5 (n=4), 12 (n=8), or 20
(n=5) h of reperfusion (I-R) and their
corresponding  sham-operated  eyes.
Note that phosphorylated ERK1/2 (p-
ERK1/2) levels were higher in the eyes
subjected to ischemia followed by 5 h of
reperfusion.  Values  are  presented  as
means±standard  error  of  the  mean.
Statistical  comparison  was  performed
using  a  paired  Student  ratio  t  test
(ischemia  versus  sham-operated  eyes)
with Bonferroni correction.
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DNA ratio recorded. Reverse transcription of total RNA to
cDNA was performed using the GeneAmp RNA PCR kit
(Applied Biosystems, Foster City, CA) in a Perkin-Elmer
DNA  thermal  cycler  (Perkin-Elmer  Applied  Biosystems).
First-strand cDNA was synthesized from 1 μg total RNA in a
40-μl reaction using random hexamers as primers.
Real-time  PCR  primers  were  retrieved  using  Primer3
software  [20]  or  the  Universal  ProbeLibrary  from  Roche
[21]. Gene-specific primer pairs were designed for each gene
based on expressed sequence tags from cDNA libraries or
computational  gene  prediction  of  orthologous  conserved
sequences (Table 1).
Real-time PCR was performed in a GeneAmp 7300 real-
time PCR systems (Applied Biosystems) using the GeneAmp
SYBR® Green kit (Applied Biosystems), with the cDNA
synthesized above as the template in a 25 µl reaction. Real-
time PCR was performed with the following profile: 1 cycle
of 50 °C for 2 min, and 95 °C for 10 min followed by 40 cycles
of 95 °C for 15 s, and 60 °C for 1 min. This was followed by
dissociation, 1 cycle of 95 °C for 15 s, 60 °C for 30 s and 95 °C
for 15 s. For more details of the reverse transcription and real-
time PCR setup and running profile, see Gesslein et al. [18].
mRNA content was calculated relative to the amount of
the housekeeping gene β-actin (ACTB). Previous analysis has
shown  that  the  use  of  ACTB  and  elongation  factor-1α
(EF-1α) as housekeeping genes give similar results [18]. The
standard curves for each primer pair had similar slopes (3.3
for GFAP, 3.1 for ERK1, 3.3 for ERK2, 3.0 for p38α, 3.3 for
JNK1, 3.1 for JNK2, 3.1 for JNK3, 3.6 for c-jun, and 3.1 for
ACTB), indicating that the cDNA was amplified with similar
efficiency.
Western blot: Protein was extracted as previously described
[18].  In  brief,  the  flow-through  was  collected  from  RNA
extraction and incubated with ice-cold acetone. The samples
were centrifuged, and the supernatant was discarded. The
protein pellet was air dried and resuspended in 8 M urea. TheFigure 6. Extracellular signal-regulated kinase 1 and 2 (ERK1 and ERK2) mRNA levels in the neuroretina. ERK1 and ERK2 mRNA expression
levels were assessed using real-time PCR in eyes subjected to ischemia and 5 (n=11), 12 (n=8), or 20 (n=6) h of reperfusion (I-R) in relation
to sham-operated eyes. Note the initial reduction in both ERK1 and ERK2 after ischemia and 5 h of reperfusion. Values are presented as means
±standard error of the mean. Statistical comparison was performed using a paired Student ratio t-test (ischemia versus sham-operated eyes)
with Bonferroni correction.
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total protein concentration was determined using a Bio-Rad
DC  kit  (Hercules,  CA).  Protein  samples  were  used
immediately for western blot analysis or stored at −80 °C.
Protein levels were measured in the neuroretina and in
the  retinal  arteries.  Protein  samples  were  mixed  with
NuPAGE LDS sample buffer (Invitrogen, Carlsbad, CA) and
incubated at 70 °C for 10 min. Equal amounts of protein
(20 µg/lane) were loaded onto a NuPAGE 4%–12% Bis-Tris
Gel (Invitrogen) and separated by sodium dodecyl sulfate–
PAGE.  A  molecular  weight  marker  (SeeBlue®  Plus2;
Invitrogen)  was  loaded  onto  each  gel  for  protein  band
identification. After separation, the proteins were transferred
to  a  polyvinylidene  difluoride  (PVDF)  membrane
(Invitrogen). The membrane was subsequently blocked with
5% nonfat milk in Tris-buffered saline with 0.1% Tween-20
(T-TBS) for 1 h at room temperature, and then washed with
T-TBS. The membranes were incubated overnight at 4 °C with
the primary antibodies of interest: 1:1,000 rabbit monoclonal
phosphospecific  anti-ERK1/2  (#4370;  Cell  Signaling
Technology), 1:500 rabbit polyclonal phosphospecific anti-
p38 (#9211; Cell Signaling Technology), mouse monoclonal
phosphospecific  anti-JNK1/2/3  (sc-6254;  Santa  Cruz
Biotechnology),  mouse  monoclonal  anti-ERK1/2  (#4696;
Cell Signaling Technology), or 1:5,000 mouse monoclonal
β-actin  (sc-47778;  Santa  Cruz  Biotechnology).  Incubation
was followed by washing with T-TBS. The membranes were
then  incubated  with  the  appropriate  secondary  antibody:
1:500 swine polyclonal antirabbit Immunoglobulin G (IgG)-
horseradish  peroxidase  (P0217;  Dako)  or  1:500  rabbit
polyclonal  antimouse  IgG-horseradish  peroxidase  (P0260;
Dako) for 2 h at room temperature, followed by washing with
T-TBS. Levels of β-actin were used to confirm equal loading
of  the  lanes.  The  membranes  were  developed  using
Amersham ECL Plus Western Blotting Detection Reagents
(GE Healthcare, Little Chalfont, UK) and visualized using a
Fujifilm  LAS-1000  luminescent  image  analyzer  (Fujifilm,
Stamford, CT). Blot intensity was quantified using ImageJ
software [22].
Statistical analysis: Statistical analysis was performed using
paired  Student  ratio  t  test  with  Bonferroni  correction  for
multiple comparisons when comparing two groups and one-
way  ANOVA  when  comparing  three  groups  or  more.
Calculations  and  statistics  were  performed  using  the
GraphPad 5.0 software (GraphPad Software, Inc., La Jolla,
CA). Exact p values are given in the text and figures. Values
are presented as means±standard error of the mean (SEM).
RESULTS
Histology and pyknotic cell nuclei count: Pyknotic cell nuclei
were detected in the retinal outer nuclear layer (ONL), INL,
and ganglion cell layer (GCL) from ischemia-reperfusion eyes
in ten out of 17 animals (66.5±12.3 cells/0.5 mm in the INL,
which equals 15.3±2.5% of the total cell count, n=10) but were
virtually absent in sham-operated eyes (2.7±1.0 cells/0.5 mm
in the INL, p=0.002, which equals 0.6±0.2%, p=0.0012, n=17,
quantified in the INL, Figure 1). The pyknotic cell count was
similar after 5 (n=5), 12 (n=7), or 20 h (n=5) of reperfusion
(p=0.2616). The number of pyknotic cell nuclei was lower in
the peripheral retina than in the central retina (20.0±4.2 and
66.5±12.3 cells/0.5 mm, respectively, in INL, p<0.001, which
equals  4.8±1.0%  and  15.3±2.5%,  respectively,  p=0.0012,
n=10).
Pyknotic cell nuclei were detected in the vascular walls
of the retinal arteries and veins from the ischemia-reperfusioneyes, while absent in the sham-operated fellow eyes (Figure
1).
Terminal  deoxynucleotidyl  transferase  dUTP  nick  end
labeling staining: TUNEL-positive cells were observed in
retinas  from  ischemia-reperfusion  eyes,  while  absent  in
retinas from sham-operated eyes. TUNEL-positive cells were
found mainly in the INL of the retina and less frequently in
the GCL and ONL of the retina (Figure 2). The number of
TUNEL-labeled cells increased gradually with the duration of
reperfusion, being detectable after 5 h of reperfusion and more
prominent after 12 and 20 h of reperfusion (Figure 2). TUNEL
staining  revealed  cells  at  different  stages  of  nuclear
degeneration. At 12 h of reperfusion, most TUNEL-positive
cells exhibited nuclei with round-condensed or ring-shaped
staining, while at 20 h of reperfusion there were also numerous
labeled  fragments  and  cellular  debris.  There  were  less
TUNEL-positive cells in the peripheral retina compared to the
central  retina.  TUNEL-positive  cells  were  occasionally
detected in the retinal arteries and veins in the ischemia-
reperfusion eyes. As for the pyknotic cell nuclei count, the
number of TUNEL-positive cells varied between animals. The
pigs that had high numbers of TUNEL-positive cells also had
high pyknotic cell counts and vice versa.
Glial  fibrillary  acidic  protein  mRNA  expression:  GFAP
mRNA expression levels were higher in the neuroretinas from
ischemia-reperfusion eyes than from sham-operated eyes and
increased gradually with increasing duration of reperfusion
(Figure 3).
Extracellular signal-regulated kinase 1 and 2 protein and
mRNA:  Phosphorylated  ERK1/2  protein  expression  was
examined in retinal sections obtained from eyes subjected to
ischemia  and  5,  12,  or  20  h  of  reperfusion  and  the
corresponding sham-operated eyes. Phosphorylated ERK1/2
protein  expression  was  higher  in  neuroretinas  from  eyes
Figure 7. Phosphorylated p38 immunofluorescence in the retinal arteries and neuroretina. A: A representative example of phosphorylated p38
(p-p38; green) staining of the retinal arteries is shown. Double staining with the smooth muscle cell marker smooth muscle actin (SMA; red)
and the endothelium cell marker CD31 (red) shows that p-p38 is primarily located in the smooth muscle layer. Similar results were seen for
sham-operated and ischemia-reperfusion eyes. B: p-p38 (green) was also occasionally detected in the inner nuclear layer of the neuroretina.
Double staining with protein kinase Cα (PKCα; red), a bipolar cell marker, showed that p38 was localized to bipolar cell bodies, whereas the
p38 protein appears to be associated with the nucleus. The abbreviations used in the figure are outer nuclear layer (ONL), outer plexiform
layer (OPL), and inner plexiform layer (IPL).
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400subjected to ischemia and 5 h of reperfusion than in sham-
operated eyes, as shown by both immunofluorescence and
western  blot  (Figure  4  and  Figure  5).  The  difference  in
phosphorylated ERK1/2 staining gradually decreased over
time and was slight after ischemia and 12 h of reperfusion and
virtually absent after ischemia and 20 h of reperfusion (Figure
4). ERK1 and ERK2 mRNA levels were examined using real-
time PCR. ERK1 and ERK2 levels were slightly reduced after
ischemia  and  5  h  of  reperfusion,  whereas  they  remained
unaltered  after  ischemia  and  12  and  20  h  of  reperfusion
(Figure 6).
Phosphorylated ERK1/2 staining appears to be located in
the Müller cells, including both the cell bodies and the radial
processes.  Phosphorylated  ERK1/2  staining  was  also
observed  in  the  inner  retina,  probably  in  the  Müller  cell
endfeet  and  astrocytes.  Retinal  arteries  did  not  stain  for
phosphorylated ERK1/2.
p38  protein  and  mRNA:  Immunofluorescence  analysis
showed staining for p38 in retinal arteries and less prominent
staining  in  the  neuroretina  (Figure  7).  The  expression  of
phosphorylated p38 protein and mRNA was not affected by
ischemia, according to immunofluorescence, western blot, or
real-time PCR analysis (Figure 8 and Figure 9).
Double staining with an endothelial cell marker (CD31),
and smooth muscle actin showed that phosphorylated p38
staining was primarily localized to the smooth muscle cell
layer of the arteries (Figure 7A). Phosphorylated p38 was
occasionally detected in the inner nuclear layer of the retina.
Double  staining  with  protein  kinase  Cα  showed  that
phosphorylated p38 was localized to bipolar cell bodies where
it appeared to stain the nucleus (Figure 7B).
c-jun  NH2-terminal  kinase  protein  and  mRNA:
Immunofluorescence  analysis  showed  staining  for  p-
JNK1/2/3 in retinal arteries and less prominent staining in the
GCL and INL of the neuroretina (Figure 10). Quantification
of  phosphorylated  JNK  protein  in  retinal  arteries  and
neuroretina with western blot showed slightly lower levels
after  ischemia  and  5  h  of  reperfusion,  while  levels  were
unchanged  after  ischemia  and  12  or  20  h  of  reperfusion
(Figure 11). JNK1, JNK2, and JNK3 mRNA expressions in
the neuroretina were slightly decreased after ischemia and 5
Figure  8.  Phosphorylated  p38  protein
content  in  the  retinal  arteries  and
neuroretina. Data are presented as mean
optical  density  (A  and  B)  and
representative western blots (C and D)
from animals subjected to ischemia and
5  (n=4),  12  (n=8),  or  20  (n=5)  h  of
reperfusion  (I-R)  and  their
corresponding  sham-operated  eyes.
Note  that  there  was  no  difference  in
phosphorylated p38 (p-p38) expression
between sham-operated and ischemia-
reperfusion eyes. Values are presented
as means±standard error of the mean.
Statistical  comparison  was  performed
using  a  paired  Student  ratio  t  test
(ischemia  versus  sham-operated  eyes)
with Bonferroni correction.
Figure  9.  p38α  mRNA  levels  in  the
retinal arteries and the neuroretina. p38α
mRNA expression levels assessed with
real-time  PCR  in  eyes  subjected  to
ischemia and 5 (n=11), 12 (n=8), or 20
(n=6)  h  of  reperfusion  (I-R)  versus
sham-operated eyes. Note that there was
no  difference  in  p38α  expression
between sham-operated and ischemia-
reperfusion eyes. Values are presented
as means±standard error of the mean.
Statistical  comparison  was  performed
using  a  paired  Student  ratio  t  test
(ischemia  versus  sham-operated  eyes)
with Bonferroni correction.
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401h of reperfusion but unchanged after ischemia and 12 or 20 h
of reperfusion (Figure 12) compared to sham-operated eyes.
c-jun protein and mRNA: Immunofluorescence staining for
total  and  phosphorylated  c-jun  was  more  intense  in  the
neuroretina from eyes subjected to ischemia and 5, 12, and 20
h of reperfusion than in the neuroretina from sham-operated
eyes (Figure 13). c-jun mRNA expression was higher after
ischemia and 5 h of reperfusion and then gradually decreased
over time, being less prominent after ischemia and 12 and 20
h of reperfusion (Figure 14).
Total  and  phosphorylated  c-jun  immunofluorescence
staining was located in the Müller cell bodies of the INL and
the ganglion cells and displaced amacrine cells of the GCL.
DISCUSSION
The present study was designed to examine changes in the
expression  of  intracellular  signal-transduction  pathways,
specifically the MAPK pathways, during the development of
retinal injury following circulatory failure. A porcine model
of retinal ischemia-reperfusion was used to enable detailed
studies of both the retinal vasculature and the neuroretina.
Experiments were performed to determine the extent of retinal
damage in this model of retinal ischemia. The pig was chosen
for  the  model  since  its  eye  has  a  typical  primate-like
architecture, including retinal blood vessels that are suitable
for  experimental  analysis  [23-25].  The  results  showed
significant retinal ischemic injury and altered expression of
MAPK.  Phosphorylated  ERK1/2  and  c-jun  levels  were
increased in the neuroretina following ischemia. Interestingly,
phosphorylated p38 and JNK1/2/3 expression was especially
high in the retinal arteries.
Retinal cell injury and glial activation: Histopathological
analysis revealed large numbers of pyknotic cell nuclei in
retinas from eyes subjected to ischemia-reperfusion that were
virtually  absent  in  the  sham-operated  eyes.  Furthermore,
TUNEL-positive cells were found in the retinas from the
ischemia-reperfusion  eyes,  indicating  that  irreversible
damage had been produced. Evaluating the degree of retinal
cell  damage  is  a  common  way  to  quantify  the  degree  of
ischemic injury [1]. In the present study, GFAP mRNA levels
increased in the retinas subjected to ischemia-reperfusion,
indicating that an insult that triggers a molecular response had
indeed  taken  place.  It  is  well  known  that  expression  of
intermediate filaments, such as GFAP, is increased in retinal
glial cells as a reaction to injury, including ischemia [26-28].
GFAP levels increased early and were already present after 5
Figure 10. Phosphorylated c-junNH2-terminal kinase 1, 2 and 3 (JNK1/2/3) immunofluorescence in the retinal arteries and neuroretina. A:
Representative example of phosphorylated JNK staining of the retinal arteries. B: Phosphorylated JNK was also detected in the ganglion cell
layer (GCL) and the inner nuclear layer (INL), but not in the outer nuclear layer (ONL) of the neuroretina. Similar results were seen for sham-
operated and ischemia-reperfusion eyes.
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402h of ischemia-reperfusion when there were only few TUNEL-
positive cells. It therefore appears that GFAP expression is a
reaction to damage of the neuronal or glial cells and not
necessarily a response to neuronal cell loss. The extent of
retinal injury in this model of retinal ischemia has been shown
before, using a multifocal electroretinogram (mfERG) [29].
The  mfERG  recordings  were  altered  following  ischemia-
reperfusion, with amplitudes of the mfERG waveforms being
decreased  and  the  implicit  time  increased  [29],  which  is
typical for retinal ischemia [30]. Taken together, the results
suggest that ischemic injury had been produced, as indicated
in previously established models of retinal ischemia [1].
Extracellular  signal-regulated  kinase  1  and  2  in
ischemia:  ERK  is  a  MAPK  known  to  mediate  cellular
responses  initiated  by  mitogens,  which  ultimately  lead  to
stimulation  of  the  transcription  factors  involved  in
differentiation and proliferation [14]. Our study and other
studies  have  shown  that  the  ERK  pathway  may  also  be
involved in the process of cell death [6]. The results obtained
in the present study show that phosphorylated ERK1/2 levels
are elevated in the neuroretina following ischemia. These
results are in line with previous studies in rats that showed
increased phosphorylated ERK1/2 levels in the neuroretina
following  ischemia  [15,16].  Roth  et  al.  induced  retinal
ischemia in the rat by elevating the IOP and found an increase
in phosphorylated ERK1/2 levels in the neuroretina. They also
reported that inhibition of ERK1/2 using U0126 prevented the
development of injury following retinal ischemia, as shown
by a reduced number of TUNEL-positive cells, recovery of
the  electroretinogram  b-wave,  and  prevention  of  retinal
thinning 7 days after ischemia [16].
In  the  present  study,  phosphorylated  ERK1/2  was
detected in the Müller cells. This is in line with the results of
previous studies showing phosphorylated ERK1/2 in Müller
cell  bodies,  radial  processes,  and  astrocytic  projections
following ischemia [15,16]. ERK1/2 activation has also been
detected in Müller cells in several other animal models and
human tissue of retinal damage, including retinal detachment
[31,32] and glaucoma [33]. The present results suggest that
the ERK1/2 pathway plays a role in retinal ischemia.
ERK1/2  has  also  been  shown  to  play  a  role  in  the
development of injury following ischemia in the brain and
heart [7,8,34,35], and ERK1/2 inhibitors have been shown to
prevent pathological changes in the vasculature after stroke
Figure  11.  Phosphorylated  c-junNH2-
terminal kinase (JNK) protein content in
the retinal arteries and neuroretina. Data
are presented as mean optical density (A
and B) and representative western blots
(C and D) from animals subjected to
ischemia and 5 (n=4), 12 (n=6), or 20
(n=5) h of reperfusion (I-R) and their
corresponding  sham-operated  eyes.
Values are presented as means±standard
error of the mean. Statistical comparison
was performed using a paired Student
ratio  t  test  (ischemia  versus  sham-
operated  eyes)  with  Bonferroni
correction.
Figure 12. c-junNH2-terminal kinase 1, 2 and 3 (JNK 1, JNK2, and JNK3) mRNA levels in the neuroretina. JNK1, JNK2, and JNK3 mRNA
expression levels were assessed using real-time PCR in eyes subjected to ischemia and 5 (n=11), 12 (n=8), or 20 (n=6) h of reperfusion (I-R)
versus sham-operated eyes. Values are presented as means±standard error of the mean. Statistical comparison was performed using a paired
Student ratio t test (ischemia versus sham-operated eyes) with the Bonferroni correction.
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403and  ischemic  heart  disease  [9,10].  Increases  in  ERK1/2
phosphorylation after ischemia may be both beneficial and
detrimental. ERK1/2 activity may increase inflammation by
upregulating interleukin 1β, leading to necrosis, or may block
apoptosis by enhancing the levels of the anti-apoptotic protein
Bcl-2 [34].
p38 in ischemia: p38 is activated by environmental stress
such as oxidative stress, ischemia and inflammatory cytokines
[14]. p38 has also been shown to be involved in cell death
[36]. Upon activation, p38 activates transcription factors. p38
also  controls  the  activator  protein  1  (AP-1)  binding  site,
thereby regulating the expression of genes, including c-jun
[37]. In the present study, the expression levels of p38 were
not affected by ischemia. Interestingly, immunofluorescence
analysis showed staining for p38 in retinal arteries, while less
prominent staining was seen in the neuroretina. p38 is known
to  mediate  contractile  responses  to  receptor  agonists  in
vascular  smooth  muscle  [38,39],  which  may  explain  the
constitutive expression of phosphorylated p38 in the retinal
arteries.  Ischemia  induced  by  middle  cerebral  arterial
occlusion  or  subarachnoid  hemorrhage  in  rats  resulted  in
increased p38 activation in the middle cerebral artery, circle
of Willis arteries, and cerebral microvessels [40,41]. In the
present  study  no  difference  was  seen  in  the  levels  of
phosphorylated  p38  in  the  blood  vessels  between  sham-
operated and ischemia-reperfusion eyes. The reason for this
discrepancy cannot be deduced from the present study but may
lie in a difference in tissue, ischemic insult, or time points
studied.  p38  has  also  been  shown  to  be  constitutively
expressed  in  neuronal  tissue.  Lee  et  al.  [42]  reported
Figure 13. Total and phosphorylated c-jun immunofluorescence in the retina. Representative examples showing immunofluorescence staining
of retina from pigs subjected to ischemia followed by 5 (n=3), 12 (n=4), or 20 (n=3) h of reperfusion and the corresponding sham-operated
eyes. Note that the immunofluorescence staining intensities for both total and phosphorylated c-jun are higher in the ischemia-reperfusion
eyes than in the sham-operated eyes. The abbreviations used in the figure are outer nuclear layer (ONL), inner nuclear layer (INL), and ganglion
cell layer (GCL).
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404constitutive expression of activated p38α and p38β in normal
adult mouse brain, suggesting that the p38 pathway may not
only be involved in inflammation and neuronal cell death but
also in normal physiology. In the present study, p38 was
localized to the bipolar cells of the INL, which is in line with
previous findings showing that p38 was expressed in bipolar
and  amacrine  cells  in  a  rat  model  of  retinal  ischemia-
reperfusion [16].
c-junNH2-terminal kinase in ischemia: JNK are activated
in response to a variety of noxious treatments, including heat
shock,  oxidant  stress,  reperfusion  injury,  and  mechanical
sheer stress as well as to cytokines and growth factors [43]. In
the present study phosphorylated JNK1/2/3 was detected in
the GCL and INL of the neuroretina. This is in line with a
previous study on rat retina [16]. Phosphorylated JNK was
also detected in the retinal arteries in both the sham-operated
and  ischemia-reperfusion  eyes.  Western  blot  experiments
confirmed  the  presence  of  phosphorylated  JNK  in  the
neuroretina and retinal arteries.
c-jun  in  ischemia:  c-jun  can  form  homodimers  or
heterodimers with c-fos to form the AP-1 transcription factor.
It can also form complexes with other transcription factors,
such  as  activating  transcription  factor.  AP-1  transcription
factor regulates the expression of genes that are important in
cell injury/repair and proliferation/differentiation, such as fas
ligand  (FasL),  tumor  necros  factor α  ( TNF-α),  and
cyclooxygenase-2 (COX-2) [44]. In the present study, total
and phosphorylated c-jun levels were increased following
Figure  14.  c-jun  mRNA  levels  in  the  neuroretina.  c-jun  mRNA
expression  levels  were  assessed,  using  real-time  PCR,  in  eyes
subjected to ischemia and 5 (n=10), 12 (n=8), or 20 (n=6) h of
reperfusion (I-R) versus sham-operated eyes. Note that the c-jun
mRNA levels are higher in eyes subjected to ischemia and 5 h of
reperfusion than in sham-operated eyes. Values are presented as
means±standard  error  of  the  mean.  Statistical  comparison  was
performed using a paired Student ratio t test (ischemia versus sham-
operated eyes) with the Bonferroni correction.
ischemia-reperfusion, suggesting that c-jun plays a role in
retinal  ischemia.  Previous  studies  using  rats  have  shown
similar findings. c-jun mRNA levels in the retina were found
to be increased after ischemia induced by elevating the IOP
followed by reperfusion [17]. Immunostaining for c-jun was
observed in both the INL and the GCL of the neuroretina.
Similarly, c-jun expression was observed by Dijk et al. in both
the INL and the GCL [17].
Enhanced activity of c-jun is a common and critical event
in cerebral ischemia and stroke [44]. In a mouse model of
retinopathy of prematurity, c-jun was inhibited by the catalytic
DNA molecule Dz13 and small interference RNA (siRNA)
[45]. This inhibition reduced the neovascularization in the
retina  as  well  as  decreased  the  vascular  permeability  and
inflammation.
The results of the present study show that the MAPK
signaling  pathways  ERK1/2  and  c-jun  were  activated  by
retinal ischemia-reperfusion. The reason for this cannot be
deduced from the present study but may depend on the many
signaling  pathways  known  to  be  activated  by  ischemia.
MAPK pathways have been shown to be stimulated by several
events that follow ischemia, including (1) cellular stress, such
as changes in osmolarity, metabolism, and DNA damage; (2)
the release of factors such as cytokines, glutamate, and growth
factors; and (3) the increase in intracellular calcium and free
radicals [7].
The duration of reperfusion time: Retinal injury due to
ischemia develops differently with time. In the present study,
both the ERK1/2 and c-jun levels were elevated after ischemia
and 5 h of reperfusion and then gradually decreased, being
less prominent after ischemia followed by 12 and 20 h of
reperfusion. Similar findings were observed in a study by
Akiyama et al. [15] in which phosphorylated ERK1/2 levels
increased early after ischemia (1 and 6 h of reperfusion) but
not  later  (after  24  h  of  reperfusion).  The  reason  for  this
fluctuation  in  ERK1/2  and  c-jun  levels  is  not  known.
Numerous other studies have also shown that there is an initial
episode of cell death after ischemia in the retina [16,46,47]
and that the degree of cell death correlates to the activity of
the MAPK signaling pathways, including those of ERK1/2
and c-jun [16,48].
Conclusions:  The  present  animal  model  produced
ischemic injury to the retina as verified by the presence of
pyknotic  cell  nuclei,  TUNEL-labeled  cells,  and  increased
GFAP mRNA levels. The MAPK signaling pathways were
affected by retinal ischemia. There was an early increase in
ERK1/2 and c-jun levels in the neuroretina, while JNK was
slightly  decreased.  p38  expression  was  not  affected  by
ischemia. The present results emphasize the role of MAPKs,
in  particular  ERK1/2  and  c-jun,  in  retinal  ischemia  and
contribute  to  our  knowledge  concerning  the  intracellular
signal-transduction pathways involved in the development of
retinal injury following ischemia. This in turn may be useful
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405in  the  identification  of  new  targets  for  pharmacological
treatment.
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